| Dr Michael Van Nguyen, MD | |
|
9250 Pinecroft Drive, The Woodlands, TX 77380-3218 | |
| (269) 337-4400 | |
| (281) 364-2535 |
| Full Name | Dr Michael Van Nguyen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 9250 Pinecroft Drive, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093976342 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist The Woodlands Hospital | The woodlands, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Travis County Emergency Physicians Pa | 0840289468 | 253 |
News Archive
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Open enrollment is fast approaching for thousands of HMO members in Virginia. Every year during this period, members have the option of selecting a health plan by comparing plan benefits and monthly premiums for the upcoming year.
There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery.
› Verified 8 days ago
| Entity Name | Travis County Emergency Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962440933 PECOS PAC ID: 0840289468 Enrollment ID: O20040510000492 |
News Archive
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Open enrollment is fast approaching for thousands of HMO members in Virginia. Every year during this period, members have the option of selecting a health plan by comparing plan benefits and monthly premiums for the upcoming year.
There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery.
› Verified 8 days ago
| Entity Name | Acs Primary Care Physicians Southwest Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538101019 PECOS PAC ID: 1850204363 Enrollment ID: O20041206000027 |
News Archive
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Open enrollment is fast approaching for thousands of HMO members in Virginia. Every year during this period, members have the option of selecting a health plan by comparing plan benefits and monthly premiums for the upcoming year.
There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery.
› Verified 8 days ago
| Entity Name | Woodlands Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467989871 PECOS PAC ID: 7618245820 Enrollment ID: O20170612002580 |
News Archive
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Open enrollment is fast approaching for thousands of HMO members in Virginia. Every year during this period, members have the option of selecting a health plan by comparing plan benefits and monthly premiums for the upcoming year.
There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Van Nguyen, MD 1140 Business Center Dr Ste 201, Houston, TX 77043-2744 Ph: (713) 932-5757 | Dr Michael Van Nguyen, MD 9250 Pinecroft Drive, The Woodlands, TX 77380-3218 Ph: (269) 337-4400 |
News Archive
Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Open enrollment is fast approaching for thousands of HMO members in Virginia. Every year during this period, members have the option of selecting a health plan by comparing plan benefits and monthly premiums for the upcoming year.
There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery.
› Verified 8 days ago
Walter Kane, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11 Hammock Dunes Pl, The Woodlands, TX 77389 Phone: 713-302-1377 | |
Todd August, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9250 Pinecroft Dr, The Woodlands, TX 77380 Phone: 281-364-2300 | |
Yana Gelman, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 17200 St Lukes Way, The Woodlands, TX 77384 Phone: 936-266-3900 | |
Tarannum Fatima, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 17600 Interstate 45 S, The Woodlands, TX 77384 Phone: 936-267-5000 | |
Dr. David Charles Carlyle, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2910 Laurel Cherry Way, The Woodlands, TX 77380 Phone: 281-367-3142 Fax: 281-298-1185 | |
Dr. Jamal Rahman Rahimi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 431 Nursery Rd Ste A100, The Woodlands, TX 77380 Phone: 832-452-5840 |